Senior insider sale
MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$160.7K
6K shares
What this filing means
KARYDAS DAPHNE plans to sell 6K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $160.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001964306-26-000445
Director
Since Feb 2026
6K
Shares to sell
$160.7K
Approx. market value
3K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of employee stock options
Broker assisted cashless exercise
9/15/2026
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of employee stock options Broker assisted cashless exercise | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3K
Market value
$75.0K
6/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3K
Market value
$85.7K
9/15/2026
Total
Units
6K
Value
$160.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/17/2026 | 3K | $75.0K | — | Completed |
| Planned — Approximate Date | ||||
9/15/2026 | 3K | $85.7K | NASDAQ | Planned |
| Total | 6K | $160.7K | ||